The global market for Flu Vaccine was estimated to be worth US$ 5505 million in 2023 and is forecast to a readjusted size of US$ 7673.2 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Flu Vaccine - Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Flu Vaccine by region & country, by Type, and by Application.

The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.

Market Segmentation

Scope of Flu Vaccine - Market Report

Report Metric	Details
Report Name	Flu Vaccine - Market
Forecasted market size in 2030	US$ 7673.2 million
CAGR	4.8%
Forecasted years	2024 - 2030
Segment by Type:	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Flu Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Flu Vaccine - Market size in 2030?

Ans: The Flu Vaccine - Market size in 2030 will be US$ 7673.2 million.

What is the market share of major companies in Flu Vaccine - Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Flu Vaccine - Market share by type?

Ans: In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%.

Who are the main players in the Flu Vaccine - Market report?

Ans: The main players in the Flu Vaccine - Market are Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO

What are the Application segmentation covered in the Flu Vaccine - Market report?

Ans: The Applications covered in the Flu Vaccine - Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Flu Vaccine - Market report?

Ans: The Types covered in the Flu Vaccine - Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Market Overview

1.1 Flu Vaccine Product Introduction

1.2 Global Flu Vaccine Market Size Forecast

1.2.1 Global Flu Vaccine Sales Value (2019-2030)

1.2.2 Global Flu Vaccine Sales Volume (2019-2030)

1.2.3 Global Flu Vaccine Sales Price (2019-2030)

1.3 Flu Vaccine Market Trends & Drivers

1.3.1 Flu Vaccine Industry Trends

1.3.2 Flu Vaccine Market Drivers & Opportunity

1.3.3 Flu Vaccine Market Challenges

1.3.4 Flu Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Flu Vaccine Players Revenue Ranking (2023)

2.2 Global Flu Vaccine Revenue by Company (2019-2024)

2.3 Global Flu Vaccine Players Sales Volume Ranking (2023)

2.4 Global Flu Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Flu Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Flu Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Flu Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Flu Vaccine

2.9 Flu Vaccine Market Competitive Analysis

2.9.1 Flu Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Flu Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Trivalent Influenza Vaccine

3.1.2 Quadrivalent Influenza Vaccine

3.2 Global Flu Vaccine Sales Value by Type

3.2.1 Global Flu Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Flu Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Flu Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Flu Vaccine Sales Volume by Type

3.3.1 Global Flu Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Flu Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Flu Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Flu Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 For Children (6 months to 3 years)

4.1.2 For Adults and Children over 3 years

4.2 Global Flu Vaccine Sales Value by Application

4.2.1 Global Flu Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Flu Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Flu Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Flu Vaccine Sales Volume by Application

4.3.1 Global Flu Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Flu Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Flu Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Flu Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Flu Vaccine Sales Value by Region

5.1.1 Global Flu Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Flu Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Flu Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Flu Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Flu Vaccine Sales Volume by Region

5.2.1 Global Flu Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Flu Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Flu Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Flu Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Flu Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Flu Vaccine Sales Value, 2019-2030

5.4.2 North America Flu Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Flu Vaccine Sales Value, 2019-2030

5.5.2 Europe Flu Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Flu Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Flu Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Flu Vaccine Sales Value, 2019-2030

5.7.2 South America Flu Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Flu Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Flu Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Flu Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Flu Vaccine Sales Value

6.2.1 Key Countries/Regions Flu Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Flu Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Flu Vaccine Sales Value, 2019-2030

6.3.2 United States Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Flu Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Flu Vaccine Sales Value, 2019-2030

6.4.2 Europe Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Flu Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Flu Vaccine Sales Value, 2019-2030

6.5.2 China Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Flu Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Flu Vaccine Sales Value, 2019-2030

6.6.2 Japan Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Flu Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Flu Vaccine Sales Value, 2019-2030

6.7.2 South Korea Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Flu Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Flu Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Flu Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Flu Vaccine Sales Value, 2019-2030

6.9.2 India Flu Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Flu Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi Pasteur

7.1.1 Sanofi Pasteur Company Information

7.1.2 Sanofi Pasteur Introduction and Business Overview

7.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Pasteur Flu Vaccine Product Offerings

7.1.5 Sanofi Pasteur Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Introduction and Business Overview

7.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Flu Vaccine Product Offerings

7.2.5 CSL Recent Development

7.3 GSK

7.3.1 GSK Company Information

7.3.2 GSK Introduction and Business Overview

7.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GSK Flu Vaccine Product Offerings

7.3.5 GSK Recent Development

7.4 Mylan

7.4.1 Mylan Company Information

7.4.2 Mylan Introduction and Business Overview

7.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mylan Flu Vaccine Product Offerings

7.4.5 Mylan Recent Development

7.5 Hulan Bio

7.5.1 Hulan Bio Company Information

7.5.2 Hulan Bio Introduction and Business Overview

7.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hulan Bio Flu Vaccine Product Offerings

7.5.5 Hulan Bio Recent Development

7.6 AstraZeneca

7.6.1 AstraZeneca Company Information

7.6.2 AstraZeneca Introduction and Business Overview

7.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 AstraZeneca Flu Vaccine Product Offerings

7.6.5 AstraZeneca Recent Development

7.7 CCBIO

7.7.1 CCBIO Company Information

7.7.2 CCBIO Introduction and Business Overview

7.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 CCBIO Flu Vaccine Product Offerings

7.7.5 CCBIO Recent Development

8 Industry Chain Analysis

8.1 Flu Vaccine Industrial Chain

8.2 Flu Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Flu Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Flu Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Flu Vaccine Market Trends

Table 2. Flu Vaccine Market Drivers & Opportunity

Table 3. Flu Vaccine Market Challenges

Table 4. Flu Vaccine Market Restraints

Table 5. Global Flu Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Flu Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Flu Vaccine Sales Volume by Company (2019-2024) & (M Doses)

Table 8. Global Flu Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Flu Vaccine Price by Company (2019-2024) & (US$/Dose)

Table 10. Key Manufacturers Flu Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Flu Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Flu Vaccine

Table 13. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Flu Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Flu Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Flu Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Flu Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Flu Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Flu Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)

Table 22. Global Flu Vaccine Sales Volume by Type (2019-2024) & (M Doses)

Table 23. Global Flu Vaccine Sales Volume by Type (2025-2030) & (M Doses)

Table 24. Global Flu Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Flu Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Flu Vaccine Price by Type (2019-2024) & (US$/Dose)

Table 27. Global Flu Vaccine Price by Type (2025-2030) & (US$/Dose)

Table 28. Global Flu Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Flu Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Flu Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Flu Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Flu Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Flu Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)

Table 34. Global Flu Vaccine Sales Volume by Application (2019-2024) & (M Doses)

Table 35. Global Flu Vaccine Sales Volume by Application (2025-2030) & (M Doses)

Table 36. Global Flu Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Flu Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Flu Vaccine Price by Application (2019-2024) & (US$/Dose)

Table 39. Global Flu Vaccine Price by Application (2025-2030) & (US$/Dose)

Table 40. Global Flu Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Flu Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Flu Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Flu Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Flu Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Flu Vaccine Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030

Table 46. Global Flu Vaccine Sales Volume by Region (2019-2024) & (M Doses)

Table 47. Global Flu Vaccine Sales Volume by Region (2025-2030) & (M Doses)

Table 48. Global Flu Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Flu Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)

Table 51. Global Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)

Table 52. Key Countries/Regions Flu Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Flu Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Flu Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Flu Vaccine Sales Volume, (2019-2024) & (M Doses)

Table 56. Key Countries/Regions Flu Vaccine Sales Volume, (2025-2030) & (M Doses)

Table 57. Sanofi Pasteur Company Information

Table 58. Sanofi Pasteur Introduction and Business Overview

Table 59. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 60. Sanofi Pasteur Flu Vaccine Product Offerings

Table 61. Sanofi Pasteur Recent Development

Table 62. CSL Company Information

Table 63. CSL Introduction and Business Overview

Table 64. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 65. CSL Flu Vaccine Product Offerings

Table 66. CSL Recent Development

Table 67. GSK Company Information

Table 68. GSK Introduction and Business Overview

Table 69. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 70. GSK Flu Vaccine Product Offerings

Table 71. GSK Recent Development

Table 72. Mylan Company Information

Table 73. Mylan Introduction and Business Overview

Table 74. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 75. Mylan Flu Vaccine Product Offerings

Table 76. Mylan Recent Development

Table 77. Hulan Bio Company Information

Table 78. Hulan Bio Introduction and Business Overview

Table 79. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 80. Hulan Bio Flu Vaccine Product Offerings

Table 81. Hulan Bio Recent Development

Table 82. AstraZeneca Company Information

Table 83. AstraZeneca Introduction and Business Overview

Table 84. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 85. AstraZeneca Flu Vaccine Product Offerings

Table 86. AstraZeneca Recent Development

Table 87. CCBIO Company Information

Table 88. CCBIO Introduction and Business Overview

Table 89. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 90. CCBIO Flu Vaccine Product Offerings

Table 91. CCBIO Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Flu Vaccine Downstream Customers

Table 95. Flu Vaccine Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Flu Vaccine Product Picture

Figure 2. Global Flu Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Flu Vaccine Sales Volume (2019-2030) & (M Doses)

Figure 5. Global Flu Vaccine Sales Price (2019-2030) & (US$/Dose)

Figure 6. Flu Vaccine Report Years Considered

Figure 7. Global Flu Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Flu Vaccine Players Sales Volume Ranking (2023) & (M Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Flu Vaccine Revenue in 2023

Figure 10. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Trivalent Influenza Vaccine Picture

Figure 12. Quadrivalent Influenza Vaccine Picture

Figure 13. Global Flu Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Flu Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Flu Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)

Figure 16. Global Flu Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Flu Vaccine Price by Type (2019-2030) & (US$/Dose)

Figure 18. Product Picture of For Children (6 months to 3 years)

Figure 19. Product Picture of For Adults and Children over 3 years

Figure 20. Global Flu Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Flu Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Flu Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)

Figure 23. Global Flu Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Flu Vaccine Price by Application (2019-2030) & (US$/Dose)

Figure 25. North America Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Flu Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Flu Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Flu Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Flu Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Flu Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Flu Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Flu Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Flu Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Flu Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Flu Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Flu Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Flu Vaccine Industrial Chain

Figure 59. Flu Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions